Kerala Ayurveda
321.00
+2.60(+0.82%)
Market Cap₹387.14 Cr
PE Ratio-17.15
IndustryHealthcare
Company Performance:
1D+0.82%
1M-8.21%
6M-40.01%
1Y-20.33%
5Y+563.22%
View Company Insightsright
More news about Kerala Ayurveda
14Nov 25
Kerala Ayurveda Reports Q2 FY2025 Results: Consolidated Loss Widens Amid Revenue Growth
Kerala Ayurveda's Q2 FY2025 results show consolidated revenue growth of 21.76% to Rs. 3,483.85 lakhs. However, the company faced profitability challenges with a standalone net loss of Rs. 540.06 lakhs and a consolidated net loss of Rs. 635.94 lakhs, compared to a profit in Q1. Total assets stood at Rs. 13,545.80 lakhs with Rs. 490.98 lakhs in cash and cash equivalents. The Board approved these unaudited results on November 14, 2025.
04Sept 25
Kerala Ayurveda Promoter Katra Phytochem Offloads Substantial Stake in Open Market
Katra Phytochem (India) Private Limited, a promoter of Kerala Ayurveda Limited, has sold 324,000 equity shares in the open market on September 2 and 3, 2025. This reduced Katra Phytochem's shareholding from 324,399 shares (2.69% of total voting capital) to just 399 shares (0.00%). The sale was disclosed to the Bombay Stock Exchange on September 4, 2025, in compliance with SEBI regulations. Kerala Ayurveda's total equity share capital remains unchanged at 12,060,198 shares.
05Aug 25
Kerala Ayurveda: Promoter Katra Phytochem Reduces Stake to 2.70% in Open Market Sale
Katra Phytochem (India) Private Limited, a promoter of Kerala Ayurveda Limited (KAL), sold 200,000 equity shares in the open market on August 04, 2025. This transaction reduced Katra Phytochem's shareholding from 4.36% to 2.70% of KAL's total share capital. The sale was reported in compliance with SEBI regulations. KAL's total equity share capital remains unchanged at 120,32,451 shares.
23Jun 25
Kerala Ayurveda Shares Soar 20% Amid Major Block Deals
Kerala Ayurveda Ltd. experienced a 20% stock price increase following block deals involving about 22 lakh shares (18.3% of total equity). Market sources suggest promoters as potential sellers and HNIs as buyers. The stock was trading at ₹488.00, up 13.7%, reversing its previous downtrend.
Kerala Ayurveda
321.00
+2.60
(+0.82%)
1 Year Returns:-20.33%
Industry Peers
Sun Pharmaceutical
1,737.00
(-1.08%)
Divis Laboratories
6,496.50
(+0.31%)
Torrent Pharmaceuticals
3,834.30
(+0.37%)
Cipla
1,496.30
(-0.29%)
Dr Reddys Laboratories
1,265.80
(-1.38%)
Lupin
2,107.00
(-0.31%)
Zydus Life Science
917.80
(-1.08%)
Mankind Pharma
2,193.30
(-1.63%)
Aurobindo Pharma
1,211.40
(-0.54%)
Alkem Laboratories
5,566.00
(-0.55%)